According to Warning data from Florida, Thermo Fisher has conducted layoffs in two locations in the state. This round of layoffs involves a total of 205 employees, and according to data previously released by Thermo Fisher, the company has 125000 employees worldwide.

According to a statement submitted by Thermo Fisher to regulatory authorities in Florida, the layoffs will begin on October 9, 2023 and end on March 39, 2024. According to media reports, the production of virus vectors in the area will be transferred and integrated to Plainville, MA, while other tasks such as research and development and technical work will remain in Florida. According to the previously released financial report, TMO's total revenue for Q2 2023 was $10.687 billion, a decrease of 2.58% compared to Q2 2022's $10.97 billion.

On July 6, 2023, Thermo Fisher announced the acquisition of real-world data provider CorEvitas to further strengthen its capabilities in biopharmaceutical services. From Thermo Fisher's Q2 financial report, it can be seen that although the overall performance has declined, its biopharmaceutical services related business is showing a growth trend. Some people analyze that the closure of this biopharmaceutical production base may be to better absorb fresh blood, and in the future, Thermo Fisher will strengthen its biopharmaceutical business and reduce outdated production capacity, which may become the main theme.